Immune Modulators Have Mixed Results on COVID Pneumonia

In December of 2020, URMC researchers joined the large, national ACTIV-1 clinical trial testing whether immune modulator drugs can speed recovery for patients hospitalized with COVID. Though results are mixed, the trial provides many insights for future trials and pandemics. 

New Feasibility Assessment Can Tell You What It Will Take to Run Your Clinical Trial

The Office of Clinical Research has rolled out a new feasibility assessment that University researchers can use to assess what it will take to run a proposed clinical trial as well as any relevant risks.

Office of Clinical Research Making Strides

The Office of Clinical Research is adding functionality and services – from educational opportunities to study feasibility and financial services – that will help take our clinical research enterprise to the next level.

UR CTSI Helps Make Connection that Spurs $10M Grant to Study Concussion

A URMC concussion researcher credits the UR CTSI and the Trial Innovation Network with helping him connect with researchers across the country and be a part of this new grant to study prolonged concussion symptoms in 11- to 18-year-olds.

UR CTSI’s Office of Clinical Research Welcomes Nicole Mason as New Director

Mason brings a lot of experience to her new role as director of the Office of Clinical Research, but her first priority when she starts on August 1 will be to conduct a listening tour among institutional leaders and research teams.